Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Anticancer Research|September 4, 2020
YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin ExpressionTakeshi Miyao, Hidekazu Koike, Yoshitaka Sekine, et al.
Anticancer Research|December 25, 2016
YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of SurvivinTakashi Nitta, Hidekazu Koike, Takeshi Miyao, et al.
BMC Cancer|March 22, 2025
The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivoYoshitaka Sekine, Daisuke Oka, Akira Ohtsu, et al.
Anticancer Research|October 30, 2016
Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate CancerHaruo Kato, Yosuke Furuya, Yoshiyuki Miyazawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2018
Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) studyKenichi Nakajima, Go Kaneko, Satoru Takahashi, et al.
The Prostate|July 24, 2019
An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progressionYoshiyuki Miyazawa, Yoshitaka Sekine, Nobuaki Shimizu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 20, 2021
Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort studyKenichi Nakajima, Atsushi Mizokami, Hideyasu Matsuyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 7, 2022
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancerNishimoto Koshiro, Kenichi Nakajima, Masafumi Oyama, et al.
Anticancer Research|May 31, 2022
Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysisTaiki Kamijima, Hiroshi Yaegashi, Atsushi Mizokami, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 2016
[SQUAMOUS CELL CARCINOMA WITH CLOACAL EXSTROPHY: A CASE REPORT]Akira Ohtsu, Takeshi Miyao, Hidekazu Koike, et al.
Pageof 1